Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
abbreviation
|
| gptkbp:administeredBy |
oral route
|
| gptkbp:category |
targeted therapy
|
| gptkbp:example |
gptkb:erlotinib
gptkb:gefitinib gptkb:dasatinib gptkb:imatinib gptkb:sunitinib |
| https://www.w3.org/2000/01/rdf-schema#label |
TKI
|
| gptkbp:mechanismOfAction |
inhibits phosphorylation of tyrosine residues
|
| gptkbp:sideEffect |
nausea
diarrhea fatigue rash liver toxicity |
| gptkbp:standsFor |
gptkb:Tyrosine_Kinase_Inhibitor
|
| gptkbp:target |
tyrosine kinases
|
| gptkbp:usedFor |
gptkb:non-small_cell_lung_cancer
gptkb:chronic_myeloid_leukemia gastrointestinal stromal tumors |
| gptkbp:usedIn |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:Bodzentyn
gptkb:Chęciny gptkb:Daleszyce gptkb:Nowa_Słupia gptkb:Strawczyn gptkb:Łopuszno gptkb:AKC_Intermediate_Trick_Dog_(TKI) gptkb:Kielce_County |
| gptkbp:bfsLayer |
7
|